Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Observation × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 4 Oropharyngeal Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Obesity 1 Neurocognitive Disorders 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Helicobacter Infections 1 Gallbladder Neoplasms 1 Cholelithiasis 1 Carcinoma, Renal Cell 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡